Northern Trust Corp Zynerba Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.33 - $1.39 $22,815 - $96,101	-69,138 Reduced 60.01%	46,072 $58,000
Q1 2023 May 15, 2023	SELL	$0.4 - $0.67 $618 - $1,036	-1,547 Reduced 1.32%	115,210 $49,000
Q3 2022 Nov 14, 2022	BUY	$0.87 - $1.36 $1,544 - $2,414	1,775 Added 1.54%	116,757 $85,000
Q2 2022 Aug 12, 2022	SELL	$0.86 - $2.06 $195 - $467	-227 Reduced 0.2%	114,982 $131,000
Q1 2022 May 13, 2022	SELL	$1.83 - $3.02 $9,625 - $15,885	-5,260 Reduced 4.37%	115,209 $236,000
Q4 2021 Feb 08, 2022	SELL	$2.88 - $4.3 $49,636 - $74,110	-17,235 Reduced 12.52%	120,469 $347,000
Q3 2021 Nov 15, 2021	BUY	$3.72 - $5.35 $63,091 - $90,736	16,960 Added 14.05%	137,704 $584,000
Q2 2021 Aug 13, 2021	BUY	$3.83 - $5.98 $80,659 - $125,938	21,060 Added 21.13%	120,744 $639,000
Q1 2021 May 12, 2021	SELL	$3.33 - $8.76 $83,423 - $219,455	-25,052 Reduced 20.08%	99,684 $463,000
Q4 2020 Feb 11, 2021	SELL	$3.27 - $4.64 $46,182 - $65,530	-14,123 Reduced 10.17%	124,736 $412,000
Q3 2020 Nov 16, 2020	BUY	$3.23 - $4.3 $15,778 - $21,005	4,885 Added 3.65%	138,859 $460,000
Q2 2020 Aug 14, 2020	SELL	$3.31 - $6.54 $646,797 - $1.28 Million	-195,407 Reduced 59.33%	133,974 $451,000
Q1 2020 May 14, 2020	BUY	$2.9 - $6.16 $38,590 - $81,971	13,307 Added 4.21%	329,381 $1.26 Million
Q4 2019 Feb 14, 2020	BUY	$5.61 - $8.57 $5,604 - $8,561	999 Added 0.32%	316,074 $1.91 Million
Q3 2019 Nov 13, 2019	BUY	$7.56 - $15.44 $1.63 Million - $3.33 Million	215,577 Added 216.66%	315,075 $2.38 Million
Q2 2019 Aug 13, 2019	BUY	$5.4 - $15.5 $143,110 - $410,781	26,502 Added 36.31%	99,498 $1.35 Million
Q1 2019 May 13, 2019	SELL	$3.6 - $6.22 $50,252 - $86,824	-13,959 Reduced 16.05%	72,996 $395,000
Q4 2018 Feb 12, 2019	SELL	$2.89 - $7.91 $23,833 - $65,233	-8,247 Reduced 8.66%	86,955 $258,000
Q3 2018 Nov 14, 2018	BUY	$5.59 - $10.45 $181,456 - $339,217	32,461 Added 51.74%	95,202 $776,000
Q2 2018 Aug 14, 2018	SELL	$7.98 - $12.39 $834,715 - $1.3 Million	-104,601 Reduced 62.51%	62,741 $612,000
Q1 2018 May 09, 2018	BUY	$8.49 - $13.46 $209,388 - $331,963	24,663 Added 17.29%	167,342 $1.46 Million
Q4 2017 Feb 14, 2018	BUY	$8.69 - $14.59 $58,979 - $99,022	6,787 Added 4.99%	142,679 $1.79 Million
Q3 2017 Nov 13, 2017	BUY	$5.73 - $9.44 $778,661 - $1.28 Million	135,892	135,892 $1.14 Million

Others Institutions Holding ZYNE

# of Institutions

Shares Held

774K

Call Options Held

Put Options Held

View Full List

About Zynerba Pharmaceuticals, Inc.

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

More about ZYNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account